137 related articles for article (PubMed ID: 32238796)
1. Connection between SOX7 Expression and Breast Cancer Prognosis.
Qin CX; Yang XQ; Zhan ZY
Med Sci Monit; 2020 Apr; 26():e921510. PubMed ID: 32238796
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of SOX7 is correlated with poor prognosis in lung adenocarcinoma patients.
Li B; Ge Z; Song S; Zhang S; Yan H; Huang B; Zhang Y
Pathol Oncol Res; 2012 Oct; 18(4):1039-45. PubMed ID: 22777918
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer.
Dong LL; Chen LM; Wang WM; Zhang LM
Diagn Pathol; 2015 Apr; 10():45. PubMed ID: 25924779
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance and prognostic value of SOX7 expression in liver and pancreatic carcinoma.
Wang J; Zhang S; Wu J; Lu Z; Yang J; Wu H; Chen H; Lin B; Cao T
Mol Med Rep; 2017 Jul; 16(1):499-506. PubMed ID: 28586005
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of SOX17 is associated with tumor progression and poor prognosis in breast cancer.
Fu DY; Tan HS; Wei JL; Zhu CR; Jiang JX; Zhu YX; Cai FL; Chong MH; Ren CL
Tumour Biol; 2015 Sep; 36(10):8025-34. PubMed ID: 25971583
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of Sox7 correlates with the upregulation of the Wnt/β-catenin signaling pathway and the poor survival of gastric cancer patients.
Cui J; Xi H; Cai A; Bian S; Wei B; Chen L
Int J Mol Med; 2014 Jul; 34(1):197-204. PubMed ID: 24788044
[TBL] [Abstract][Full Text] [Related]
7. The regulation of SOX7 and its tumor suppressive role in breast cancer.
Stovall DB; Wan M; Miller LD; Cao P; Maglic D; Zhang Q; Stampfer MR; Liu W; Xu J; Sui G
Am J Pathol; 2013 Nov; 183(5):1645-1653. PubMed ID: 24012678
[TBL] [Abstract][Full Text] [Related]
8. SOXs in human prostate cancer: implication as progression and prognosis factors.
Zhong WD; Qin GQ; Dai QS; Han ZD; Chen SM; Ling XH; Fu X; Cai C; Chen JH; Chen XB; Lin ZY; Deng YH; Wu SL; He HC; Wu CL
BMC Cancer; 2012 Jun; 12():248. PubMed ID: 22703285
[TBL] [Abstract][Full Text] [Related]
9. Sox17 promoter methylation in plasma DNA is associated with poor survival and can be used as a prognostic factor in breast cancer.
Fu D; Ren C; Tan H; Wei J; Zhu Y; He C; Shao W; Zhang J
Medicine (Baltimore); 2015 Mar; 94(11):e637. PubMed ID: 25789956
[TBL] [Abstract][Full Text] [Related]
10. SOX7 co-regulates Wnt/β-catenin signaling with Axin-2: both expressed at low levels in breast cancer.
Liu H; Mastriani E; Yan ZQ; Yin SY; Zeng Z; Wang H; Li QH; Liu HY; Wang X; Bao HX; Zhou YJ; Kou JJ; Li D; Li T; Liu J; Liu Y; Yin L; Qiu L; Gong L; Liu SL
Sci Rep; 2016 May; 6():26136. PubMed ID: 27188720
[TBL] [Abstract][Full Text] [Related]
11. SOX7 Target Genes and Their Contribution to Its Tumor Suppressive Function.
Zhang Y; Stovall DB; Wan M; Zhang Q; Chou JW; Li D; Sui G
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29757932
[TBL] [Abstract][Full Text] [Related]
12. MiR-492 contributes to cell proliferation and cell cycle of human breast cancer cells by suppressing SOX7 expression.
Shen F; Cai WS; Feng Z; Li JL; Chen JW; Cao J; Xu B
Tumour Biol; 2015 Mar; 36(3):1913-21. PubMed ID: 25407488
[TBL] [Abstract][Full Text] [Related]
13. Quantitative measurement of serum microRNA-21 expression in relation to breast cancer metastasis in Chinese females.
Wang G; Wang L; Sun S; Wu J; Wang Q
Ann Lab Med; 2015 Mar; 35(2):226-32. PubMed ID: 25729725
[TBL] [Abstract][Full Text] [Related]
14. Low expression of miR-597 is correlated with tumor stage and poor outcome in breast cancer.
Zhang XY; Liu DJ; Yuan RB; Zhang DH; Li SR; Zhang SH; Zhang LY
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):456-460. PubMed ID: 29424903
[TBL] [Abstract][Full Text] [Related]
15. Reduced expression of SOX7 in ovarian cancer: a novel tumor suppressor through the Wnt/β-catenin signaling pathway.
Liu H; Yan ZQ; Li B; Yin SY; Sun Q; Kou JJ; Ye D; Ferns K; Liu HY; Liu SL
J Ovarian Res; 2014 Sep; 7():87. PubMed ID: 25297608
[TBL] [Abstract][Full Text] [Related]
16. Down-regulated microRNA-124 expression as predictive biomarker and its prognostic significance with clinicopathological features in breast cancer patients.
Arabkheradmand A; Safari A; Seifoleslami M; Yahaghi E; Gity M
Diagn Pathol; 2015 Sep; 10():178. PubMed ID: 26415857
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
Luo M; Shen D; Wang W; Xian J
Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
[TBL] [Abstract][Full Text] [Related]
18. SOX7 methylation is an independent prognostic factor in myelodysplastic syndromes.
Xu ZJ; Tang CY; Zhou JD; Ma JC; Wen XM; Deng ZQ; Leng JY; Qiu ZY; Qian J; Lin J
Pathol Res Pract; 2019 Feb; 215(2):322-328. PubMed ID: 30554866
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of miR-330-3p: a novel independent indicator of poor prognosis in human breast cancer.
Wang H; Chen SH; Kong P; Zhang LY; Zhang LL; Zhang NQ; Gu H
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1726-1730. PubMed ID: 29630118
[TBL] [Abstract][Full Text] [Related]
20. Decreased CDK10 expression correlates with lymph node metastasis and predicts poor outcome in breast cancer patients - a short report.
You Y; Li H; Qin X; Zhang Y; Song W; Ran Y; Gao F
Cell Oncol (Dordr); 2015 Dec; 38(6):485-91. PubMed ID: 26392360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]